WEBINAR: Industrialization of the Manufacturing of a Gene Therapy Medicinal Product


Nicolas Preyat, Ph.D.
MaSTherCell, Belgium | Project and Development Manager


Recent advances in the field of gene editing technologies open new avenues for the implementation of cell and gene therapy therapeutic products. The development and manufacturing of disruptive Advanced Therapy Medicinal Products (ATMP) such as Chimeric Antigen Receptor (CAR) T cells is associated with a number of challenges. To ensure the success of the industrialization of CART from the bench to the bedside, there should be experts at each step of the process. Masthercell provides high quality services for the development and manufacturing of cell and gene therapy products in a cost and time efficient manner. Furthermore, to control the process of production and ensure the safety of the product, the complexity of the product should be characterized via appropriate analytical methods for which Masthercell can ensure the qualification/validation. MasTherCell also helps his customer through diagnostic services.

Learn more about Sartorius solutions for CAR-T Discovery & Development at www.sartorius.com/car-t-research.

Complete the form below to watch the webinar.

Are you interested in receiving more information on cell analysis instruments for your research?

Are you looking to purchase cell analysis equipment for your lab?

What other products/areas are of interest (check all that apply):

How can we assist you with these products?